Camilla Cocchi
Overview
Explore the profile of Camilla Cocchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
312
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farinetti A, Cocchi C, Coppi F, Mattioli A
Am J Lifestyle Med
. 2025 Jan;
15598276241313329.
PMID: 39802905
Cardiovascular disease (CVD) remains a significant global health concern for women, influenced by a complex interplay of social, economic, and environmental factors. This article examines cardiovascular risk through the lens...
2.
Bucciarelli V, Moscucci F, Cocchi C, Nodari S, Sciomer S, Gallina S, et al.
Am Heart J Plus
. 2024 Aug;
45:100431.
PMID: 39175598
Climate change impacts food systems, causing nutritional deficiencies and increasing cardiovascular diseases (CVD). Regulatory frameworks like the European Farm-to-Fork Strategy aim to mitigate these effects, but current EU food safety...
3.
Cocchi C, Zazzara M, Liperoti R, Antonione R, Dispenza S, Gobber G, et al.
Ann Ist Super Sanita
. 2024 Jun;
60(1):64-71.
PMID: 38920260
Background: In western countries, the increasing life expectancy and the growing number of individuals with advanced chronic conditions have resulted in a greater demand for palliative care. Specifically, Italy has...
4.
Zazzara M, Ornago A, Cocchi C, Serafini E, Bellelli G, Onder G
Eur Geriatr Med
. 2024 Mar;
15(2):397-406.
PMID: 38498073
Purpose: Delirium has been recognized as an atypical presenting feature of COVID-19 in older adults and is independently associated with mortality. We aimed to perform an updated systematic review of...
5.
Leccisotti L, Cinti F, Sorice G, DAmario D, Lorusso M, Guzzardi M, et al.
Cardiovasc Diabetol
. 2022 Sep;
21(1):173.
PMID: 36057768
Objective: Cardiovascular (CV) outcome trials have shown that in patients with type 2 diabetes (T2D), treatment with sodium-glucose cotransporter-2 inhibitors (SGLT-2i) reduces CV mortality and hospital admission rates for heart...
6.
Cacciatore S, Brandi V, Cocchi C, Elmi D, Gava G, Massaro C, et al.
Ann Geriatr Med Res
. 2022 Aug;
26(3):275-278.
PMID: 35918298
Nonconventional clinical presentations of diseases are common in older adults. Even dramatic events, such as foreign body (FB) inhalation, can occur in a subtle and non-specific manner. Pill aspiration is...
7.
Sorice G, Cinti F, Leccisotti L, DAmario D, Lorusso M, Guzzardi M, et al.
Diabetes Ther
. 2021 May;
12(7):2101-2113.
PMID: 34037951
Introduction: Sodium-glucose co-transporter-2 (SGLT-2) inhibitors have been shown to have beneficial effects on various cardiovascular (CV) outcomes in patients with type 2 diabetes (T2D) in primary prevention and in those...
8.
Cocchi C, Coppi F, Farinetti A, Mattioli A
Future Cardiol
. 2021 Mar;
17(3):487-496.
PMID: 33739145
Cardiovascular disease (CVD) is the leading cause of death among men and women, although women are usually underdiagnosed and experience a delay in diagnosis. This also occurs in women with...
9.
Mattioli A, Sciomer S, Cocchi C, Maffei S, Gallina S
Nutr Metab Cardiovasc Dis
. 2020 Jun;
30(9):1409-1417.
PMID: 32571612
Aims: CoV-19/SARS-CoV-2 is a highly pathogenic virus that is causing a global pandemic with a high number of deaths and infected people. To contain the diffusion of infection, several governments...
10.
Mattioli A, Nasi M, Cocchi C, Farinetti A
Future Cardiol
. 2020 May;
16(6):539-542.
PMID: 32351128
No abstract available.